Novan presents preliminary phase II results for SB-206 as treatment of molluscum contagiosum Nov. 15, 2018
Promising interim results presented from phase IIa study of CTP-543 in patients with alopecia areata Nov. 13, 2018
Novel RORgammat inhibitors developed by Shionogi for treating Th17-mediated autoimmune diseases Nov. 12, 2018
Discovery and optimization of Aurora B-selective SYK inhibitors as topical agents for skin diseases Nov. 8, 2018
RSS